Novo Nordisk A/S agreed to partner with the US technology company Valo Health Inc. to use artificial intelligence to find new drugs in a deal that could be worth as much as $2.7 billion.
Novo Clinches AI-Driven Drug Deal Worth as Much as $2.7 Billion
Posted in biotech/medical, health, robotics/AI